Thoracic Neoplasm — Trials

Thoracic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,160 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1,351–1,362 of 1,362 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05503667	Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma	recruiting	Phase 2	96	Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER	1	Aug 17, 2022	clinicaltrials
NCT05484583	Durvalumab Combined With Consolidation Radiotherapy After First-line Treatment in Extensive Stage Small Cell Lung Cancer With Oligometastases	not yet recruiting	Phase 2	58	Affiliated Cancer Hospital & Institute of Guangzhou Medical University